BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

N Methylscopolamine

A muscarinic antagonist used to study binding characteristics of muscarinic cholinergic receptors.

299+ PubMed studies analyzed · Evidence Score: 41.7

Research Domains

N Methylscopolamine has been studied across 18 research domains including 😴 Sleep, 🧠 Focus & Attention, 🌤️ Mood & Depression, 🔬 Oncology, 🦴 Bone & Joint. The primary research focus is 😴 Sleep with 10% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with N Methylscopolamine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Scopolamine
6 shared targets
carbachol
5 shared targets
pirenzepine
5 shared targets
oxotremorine
5 shared targets
4
5 shared targets
methscopolamine
5 shared targets
solifenacin
5 shared targets
himbacine
5 shared targets
aclidinium
5 shared targets
glycopyrronium
5 shared targets
Loading evidence profile...

This evidence profile for N Methylscopolamine is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.